Breslin & Breslin, P.A.
201.546.5881
medical malpractice & personal injurySuper-Lawyers

November 2012 Archives

New scrutiny of nursing home, hospital patients' bed rail deaths

Bed rails used in hospitals and nursing homes might at first blush seem the most innocuous of things and, when mentioned in the context of safety, deemed to be tools of the trade that enhance safety outcomes. The devices enable patients to more easily pull themselves out of bed and prevent incidents of patients falling out of beds. Through the use of safety straps, they also allow for temporary restraint of some patients -- for example, those still groggy following surgery -- who might otherwise attempt to get mobile too quickly.

NFL embraces technology to help deal with players' head injuries

Although it might not be the industry in which head injuries -- traumatic brain injuries (TBIs), including concussions -- are most prevalent, dissuading any regular viewer of professional football games of that fact might make for a difficult proposition.

Glaxo's product liability woes: latest Avandia settlement announced

It's good that London-based GlaxoSmithKline Plc (GSK), one of the world's largest pharmaceutical manufacturers, is awash in money, because the company is certainly spending it to settle criminal and civil investigations into illegal marketing and product liability matters.

New safety tech promises great changes for motorists in future

A professor and traffic safety expert at one university calls the concept of accident-free cars "very hot" and says that the technology enabling them will be sufficiently advanced to allow such vehicles to begin operating on some roads and highways in the near foreseeable future.

Delayed diagnosis may cause major harm for New Jersey patients

Most New Jersey readers have probably never heard of valley fever, an illness caused by fungal spores most common in the southern United States. Valley fever is difficult to diagnose and rare in many parts of the United States, but health experts say that even in areas where it is more common, doctors often consider it as an option only when the disease has become more severe.

Material updates in the national meningitis tragedy

We informed readers in a prior blog post (please see our October 23 entry) that we would keep them fully apprised of material developments unfolding regarding the nation's tragic meningitis outbreak that first surfaced last month.

Major medical journal announces new publishing rule on drug trials

Citing her publication's expectation "that eventually this will become the norm," the editor of the internationally prominent British Medical Journal recently discussed a material change in the journal's publishing guidelines relating to drug companies' clinical trials.